Atea Pharmaceuticals director sells 41,226 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Atea Pharmaceuticals, Inc. (AVIR) director Bruce Polsky exercised 75,000 stock options at $1.24 per share from November 16 through November 18, 2026, receiving common shares. He sold 41,226 shares across those dates: 14,254 at a weighted average $4.2683 on November 16, 8,720 at $4.0316 on November 17, and 18,252 at $3.9502 on November 18. The sales were reported as executed to pay the options’ exercise price and for tax-planning purposes. The options were fully vested and exercisable, and no Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4 | 18,252 | $0.00 | $0.00 |
| Exercise | Common Stock | 18,252 | $1.24 | $23K |
| Sale | Common Stock F3 | 18,252 | $3.9502 | $72K |
| Exercise | Stock Option (Right to Buy) F4 | 8,720 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,720 | $1.24 | $11K |
| Sale | Common Stock F2 | 8,720 | $4.0316 | $35K |
| Exercise | Stock Option (Right to Buy) F4 | 48,028 | $0.00 | $0.00 |
| Exercise | Common Stock | 48,028 | $1.24 | $60K |
| Sale | Common Stock F1 | 14,254 | $4.2683 | $61K |
Footnotes (4)
- F1. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.20 to $4.33. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.00 to $4.10. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.91 to $4.00. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The option is fully vested and exercisable.
Key Figures
Key Terms
weighted average price financial
Rule 10b5-1 plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many AVIR options did director Bruce Polsky exercise, and at what price?
AI-generated analysis. How Rhea-AI works. Not financial advice.